Doctor of Biological Sciences, Head of the Glycobiology Lab at the Institute of Molecular Biology and Biophysics of the Federal Research Center of Fundamental and Translational Medicine. Dr. Grigorieva’s main research is focused on molecular oncology and study of the role of glycosylated macromolecules and tumor microenvironment in molecular mechanisms of malignant tumor development and progression. She also studies the potential of glycosylated extracellular macromolecules to be used as prognostic markers and molecular mechanisms of chemoradiotherapy effect, its adverse effects in treatment of glioblastoma.

Dr. Grigorieva has authored more than 75 scientific publications. Under her supervision, 5 theses were defended. She is a member of editorial boards of Frontiers in Oncology, Advances in Cancer Biology – Metastasis journals